Cholera vaccine

Jul 12, 2019

Global Cholera Vaccines Market Outlook to 2024 - AstraZeneca, Shantha Biotechnics, Valneva, Merck & Co, and PaxVax are Leading the Competition

Apr 02, 2019

The global cholera vaccine market generated $65 million in 2017, and is projected to reach $207 million by 2025, growing at a CAGR of 15.6% from 2018 to 2025

Mar 04, 2019

Cholera Vaccine Market to Reach $207 Mn, Globally, by 2025 at 15.6% CAGR: Allied Market Research

Jan 29, 2019

Valneva CEO Interview - Group Strategy (video)

Aug 09, 2018

Emergent BioSolutions to Acquire PaxVax from Cerberus Capital Management

Dec 06, 2017

Randomized Placebo-Controlled Study Provides Encouraging Results for a Higher Dose Formulation of Vaxchora® (CVD 103-HgR) as a Potential Tool in Containing Cholera Epidemics

Aug 31, 2017

Valneva CEO Interview - Half Year 2017 Earnings (video)